We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$9M +$286K +8,725 +4%
IC
2
Ikarian Capital
Texas
$5.23M
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.12M
LA
4
Linden Advisors
New York
$860K
BlackRock
5
BlackRock
New York
$578K -$3.51K -107 -0.7%
BFM
6
Boothbay Fund Management
New York
$489K
Renaissance Technologies
7
Renaissance Technologies
New York
$319K +$55K +1,678 +25%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$295K
JJ
9
Johnson & Johnson
New Jersey
$159K
State Street
10
State Street
Massachusetts
$142K
Bank of New York Mellon
11
Bank of New York Mellon
New York
$126K
Corient Private Wealth
12
Corient Private Wealth
Florida
$109K
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$79.1K +$68.6K +2,094 New
Charles Schwab
14
Charles Schwab
California
$42.8K +$37.1K +1,132 New
Northern Trust
15
Northern Trust
Illinois
$41K +$7.14K +218 +25%
Citadel Advisors
16
Citadel Advisors
Florida
$37.8K +$30.1K +919 +1,149%
XSC
17
X-Square Capital
Puerto Rico
$34K -$393 -12 -1%
Jane Street
18
Jane Street
New York
$32.1K +$27.8K +849 New
H
19
HoyleCohen
California
$24.6K
MOS
20
MGO One Seven
Ohio
$22.3K
Millennium Management
21
Millennium Management
New York
$22K +$19.3K +588 New
Two Sigma Advisers
22
Two Sigma Advisers
New York
$19.5K -$70.3K -2,145 -81%
UBS Group
23
UBS Group
Switzerland
$11.4K +$8.65K +264 +714%
TRCT
24
Tower Research Capital (TRC)
New York
$6K -$8.49K -259 -61%
ASN
25
Advisory Services Network
Georgia
$3.78K